ABSTRACT
Due to resource scarcity during the pandemic, patient triage and transfer to institutions capable of cannulating and managing ECMO patients becomes important to optimize outcomes. When patients with COVID-19 ARDS fail to improve with invasive mechanical ventilation and conventional therapies, veno-venous extracorporeal membrane oxygenation (VV ECMO) may be considered. B Introduction: b Approximately one third of hospitalized patients with Coronavirus disease (COVID-19) develop acute respiratory distress syndrome (ARDS). [Extracted from the article] Copyright of Critical Care Medicine is the property of Lippincott Williams & Wilkins and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full . (Copyright applies to all s.)